A Catalog of 5' Fusion Partners in ROS1-Positive NSCLC Circa 2020
{{output}}
ROS1 fusion-positive (ROS1+) NSCLC was discovered in 2007, the same year as the discovery of ALK-positive (ALK+) NSCLC but has trailed ALK+ NSCLC in terms of development. There seems to be a differential response to ROS1 inhibitors, which depend on fusion part... ...
